|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Loan principal payments held by servicer | ||||||||||||||||||||
| Loans receivable held-for-investment | ||||||||||||||||||||
| Less: current expected credit loss reserve | ||||||||||||||||||||
| Loans receivable held-for-investment, net | ||||||||||||||||||||
| Loan receivable held-for-sale | ||||||||||||||||||||
| Equity method investment | ||||||||||||||||||||
| Real estate owned held-for-investment, net | ||||||||||||||||||||
| Real Estate Owned Held-For-Sale | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Repurchase agreements | ||||||||||||||||||||
| Term participation facility | ||||||||||||||||||||
| Loan participations sold, net | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Secured term loan, net | ||||||||||||||||||||
| Debt related to real estate owned hotel portfolio, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Management fee payable - affiliate | ||||||||||||||||||||
| Incentive fee payable - affiliate | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock, $0.01 par value, 500,000,000 shares authorized, 141,084,206 and 140,218,764 shares issued and 141,084,206 and 140,218,764 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...